Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Human UDP-glucuronosyltransferase expression in insect cells: ratio of active to inactive recombinant proteins and the effects of a C-terminal his-tag on glucuronidation kinetics.

Zhang H, Patana AS, Mackenzie PI, Ikushiro S, Goldman A, Finel M.

Drug Metab Dispos. 2012 Oct;40(10):1935-44. doi: 10.1124/dmd.112.046086. Epub 2012 Jul 10.

PMID:
22782802
2.

Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyltransferases.

Patana AS, Kurkela M, Finel M, Goldman A.

Protein Eng Des Sel. 2008 Sep;21(9):537-43. doi: 10.1093/protein/gzn030. Epub 2008 May 23.

PMID:
18502788
3.

The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis.

Xiong Y, Patana AS, Miley MJ, Zielinska AK, Bratton SM, Miller GP, Goldman A, Finel M, Redinbo MR, Radominska-Pandya A.

Drug Metab Dispos. 2008 Mar;36(3):517-22. Epub 2007 Nov 29.

4.

The human UDP-glucuronosyltransferase: identification of key residues within the nucleotide-sugar binding site.

Patana AS, Kurkela M, Goldman A, Finel M.

Mol Pharmacol. 2007 Sep;72(3):604-11. Epub 2007 Jun 19.

PMID:
17578897
5.

Interactions with other human UDP-glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6.

Kurkela M, Patana AS, Mackenzie PI, Court MH, Tate CG, Hirvonen J, Goldman A, Finel M.

Pharmacogenet Genomics. 2007 Feb;17(2):115-26.

PMID:
17301691

Supplemental Content

Loading ...
Support Center